platinum has been researched along with ifosfamide in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (30.77) | 18.2507 |
| 2000's | 4 (30.77) | 29.6817 |
| 2010's | 2 (15.38) | 24.3611 |
| 2020's | 3 (23.08) | 2.80 |
| Authors | Studies |
|---|---|
| Almadrones, L; Hakes, T; Hoskins, W; Jones, W; Lewis, JL; Markman, M; Pizzuto, F; Reichman, B; Rubin, S | 1 |
| Cabanillas, FC; Hagemeister, FB; McLaughlin, P; Rodriguez, MA; Romaguera, JE; Swan, F; Velasquez, W | 1 |
| De Ruysscher, D; Demedts, M; Spaas, P; Specenier, P; Van den Brande, P; Vansteenkiste, J | 1 |
| Coosemans, W; De Leyn, P; Deneffe, G; Lerut, T; Van Raemdonck, D; Vansteenkiste, J | 1 |
| Comerci, JT; Edwards, RP; Kanbour-Shakir, A; Kelley, JL; Kunschner, AJ; Price, FV; Sit, AS | 1 |
| Minoia, C; Ronchi, A; Sottani, C; Turci, R | 1 |
| Dorey, F; Eckardt, J; Eilber, FC; Eilber, FR; Nelson, SD; Rosen, G; Selch, M | 1 |
| Brunetti, C; Cassano, G; Colucci, G; Galetta, D; Gebbia, V; Germano, D; Giampaglia, M; Guida, M; Izzi, G; Lorusso, V; Nettis, G; Silvestris, N; Spada, M | 1 |
| Abedallaa, N; Baey, C; Besse, B; de Montpreville, VT; Fabre, D; Guigay, J; Pechoux, CL; Pignon, JP; Planchard, D; Soria, JC; Tremblay, L | 1 |
| Dong, M; Gui, L; He, X; Hu, S; Jia, B; Liu, P; Qin, Y; Yang, J; Yang, S; Zhang, C; Zhou, S | 1 |
| Adorni, M; Bazzurini, L; Buda, A; Grassi, T; Landoni, F; Lissoni, AA; Negri, S; Vecchione, F | 1 |
| Chang, WH; Chen, YJ; Huang, HY; Lee, NR; Lin, SC; Su, MH; Wang, PH; Wu, HH | 1 |
| Kimura, T; Kurita, T; Miyoshi, AI; Ueda, Y; Yoshino, K | 1 |
1 review(s) available for platinum and ifosfamide
| Article | Year |
|---|---|
Recent Advances in the Management of Small Cell Carcinoma of the Uterine Cervix.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Neuroendocrine; Carcinoma, Small Cell; Cervix Uteri; Cisplatin; Etoposide; Female; Humans; Ifosfamide; Lung Neoplasms; Neoplasm Staging; Platinum; Rare Diseases; Small Cell Lung Carcinoma; Uterine Cervical Neoplasms | 2023 |
5 trial(s) available for platinum and ifosfamide
| Article | Year |
|---|---|
Ifosfamide and mesna in previously treated advanced epithelial ovarian cancer: activity in platinum-resistant disease.
Topics: Acute Kidney Injury; Adult; Aged; Carcinoma; Drug Evaluation; Drug Resistance; Female; Humans; Ifosfamide; Mesna; Middle Aged; Ovarian Neoplasms; Platinum | 1992 |
A phase II trial of mesna/ifosfamide, mitoxantrone and etoposide for refractory lymphomas.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Etoposide; Female; Humans; Ifosfamide; Lymphoma; Male; Mesna; Middle Aged; Mitoxantrone; Platinum; Prospective Studies; Recurrence; Remission Induction; Salvage Therapy; Survival Rate; Treatment Failure | 1995 |
Sequential treatment with vindesine-ifosfamide-platinum (VIP) chemotherapy followed by platinum sensitized radiotherapy in stage IIIB non-small cell lung cancer: a phase II trial.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Drug Administration Schedule; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Platinum; Prospective Studies; Radiation-Sensitizing Agents; Radiotherapy, Adjuvant; Survival Analysis; Treatment Outcome; Vindesine | 1998 |
Result of induction chemotherapy followed by surgery in patients with stage IIIA N2 NSCLC: importance of pre-treatment mediastinoscopy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Combined Modality Therapy; Disease-Free Survival; Female; Humans; Ifosfamide; Lung Neoplasms; Lymphatic Metastasis; Male; Mediastinoscopy; Middle Aged; Neoplasm Staging; Platinum; Pneumonectomy; Prognosis; Prospective Studies; Remission Induction; Survival Analysis; Survival Rate; Vindesine | 1999 |
Topotecan plus ifosfamide in patients with platinum refractory advanced/metastatic non-small cell lung cancer: a phase II trial.
Topics: Adult; Aged; Alopecia; Anemia; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Drug Resistance, Neoplasm; Female; Humans; Ifosfamide; Infusions, Intravenous; Lung Neoplasms; Male; Middle Aged; Neutropenia; Platinum; Thrombocytopenia; Topotecan; Treatment Outcome | 2005 |
7 other study(ies) available for platinum and ifosfamide
| Article | Year |
|---|---|
Chemotherapy for malignant mixed Müllerian tumors of the ovary.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemotherapy, Adjuvant; Female; Humans; Ifosfamide; Middle Aged; Mixed Tumor, Mullerian; Neoplasm Staging; Ovarian Neoplasms; Paclitaxel; Platinum; Retrospective Studies; Survival Analysis; Taxoids; Treatment Outcome | 2000 |
Biological monitoring of hospital personnel occupationally exposed to antineoplastic agents.
Topics: Adult; Antineoplastic Agents, Alkylating; Chromatography, High Pressure Liquid; Cyclophosphamide; Environmental Monitoring; Female; Humans; Ifosfamide; Male; Mass Spectrometry; Methotrexate; Occupational Exposure; Personnel, Hospital; Platinum; Sensitivity and Specificity | 2002 |
High-grade extremity soft tissue sarcomas: factors predictive of local recurrence and its effect on morbidity and mortality.
Topics: Amputation, Surgical; Antineoplastic Agents; Antineoplastic Protocols; Combined Modality Therapy; Doxorubicin; Extremities; Female; Humans; Ifosfamide; Limb Salvage; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Platinum; Prognosis; Radiotherapy; Risk Factors; Sarcoma; Survival Analysis; Treatment Outcome | 2003 |
Effect of chemotherapy in patients with resected small-cell or large-cell neuroendocrine carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Large Cell; Carcinoma, Neuroendocrine; Cyclophosphamide; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Lung Neoplasms; Lymph Nodes; Male; Methotrexate; Middle Aged; Neoplasm Staging; Perioperative Care; Platinum; Pneumonectomy; Prognosis; Retrospective Studies; Small Cell Lung Carcinoma; Survival Rate | 2012 |
[Efficacy and safety evaluation of gemcitabine combined with ifosfamide in patients with advanced nasopharyngeal carcinoma after failure of platinum-based chemotherapy].
Topics: Anemia; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Deoxycytidine; Disease-Free Survival; Gemcitabine; Humans; Ifosfamide; Induction Chemotherapy; Kaplan-Meier Estimate; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neutropenia; Platinum; Remission Induction; Salvage Therapy; Survival Rate; Thrombocytopenia; Treatment Failure | 2015 |
Neoadjuvant chemotherapy followed by radical surgery in locally advanced vulvar carcinoma: a single-institution experience.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Female; Humans; Ifosfamide; Neoadjuvant Therapy; Neoplasm Staging; Paclitaxel; Platinum; Retrospective Studies; Uterine Cervical Neoplasms; Vulvar Neoplasms | 2022 |
Comparing paclitaxel-platinum with ifosfamide-platinum as the front-line chemotherapy for patients with advanced-stage uterine carcinosarcoma.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Female; Humans; Ifosfamide; Middle Aged; Paclitaxel; Platinum; Postoperative Period; Retrospective Studies; Uterine Neoplasms | 2022 |